期刊文献+

MTHFR基因C677T位点多态性与风湿性疾病的相关性 被引量:1

The study of the relationship of MTHFR polymorphisms with rheumatoid diseases
暂未订购
导出
摘要 目的:检测多种风湿性疾病患者亚甲基四氢叶酸还原酶(MTHFR)基因C677T位点多态性,探讨其与血浆同型半胱氨酸(Hcy)、叶酸、V itB12及其疾病的关系。方法:测定54例系统性红斑狼疮(SLE)、48例类风湿关节炎(RA)、60例强直性脊柱炎(AS)、30例未分化脊柱关节病(uSpA)患者和62例正常对照者的Hcy、V itB12、叶酸的水平,采用聚合酶链反应限制性片段长度多态性技术检测MTHFR基因677位的多态性。结果:(1)各疾病组CC基因型频率显著低于正常对照组,总的突变T等位基因频率显著高于对照组。(2)MTHFR基因677位C→T的突变使Hcy水平升高[CC型,(13.41±5.78)μmol.L-1;CT型,(16.81±4.22)μmol.L-1;TT型(20.88±6.60)μmol.L-1,P<0.001]。(3)TT基因型是高Hcy血症的易感基因,OR=84.46,P<0.05;同时还是SLE的易感基因,OR=7.56,P<0.05。结论:(1)SLE、RA、AS、uSpA 4种疾病患者普遍存在MTHFR基因C677T位突变和高Hcy血症。(2)TT型基因不仅是Hcy异常升高的易感基因,也是SLE的易感基因。 Objective To assess the relationship of methylene tetrahydrofolate reductase (MTHFR) C677T genotypes to some rheumatoid diseases. Methods 54 cases with SLE ,48 cases with RA ,60 cases with AS ,30 cases with uSpA and 62 controls were recruited into the study. Plasma Hcy, vitamin B12 ,folate were measured in all patients and controls. MTHFR gene C677T polymorphisms were detected by the technique of polymerase chain reaction-restriction fragment length polymorphism(PCR-RELP). Results ( 1 ) CC genotype in each patient group was significantly lower than that in control group, the total mutant T allele frequency was significantly higher than that in control group. ( 2 ) The MTHFR gene mutation increased Hcy level dramatically[ in CC, CT and TT genotype being( 13.41 ± 5.78 ), ( 16.81±4. 22 ), (20.88 ±6.60 ) μmol·L^-1, respectively, P 〈 0. 05 ). ( 3 ) TT genotype was susceptible to hyperhomocysteinemia and SLE( OR = 56.47,6.93 ; P 〈 0. 05 ). Conclusions ( 1 ) MTHFR C677T gene mutation and hyperhomocysteinemia are found in most SLE, RA, AS and USPA patients. (2) TT genotype of MTHFR is susceptible to hyperhomocysteinemia and SLE.
出处 《东南大学学报(医学版)》 CAS 2007年第1期38-41,共4页 Journal of Southeast University(Medical Science Edition)
关键词 亚甲基四氢叶酸还原酶 同型半胱氨酸 风湿性疾病 基因突变 methylene tetrahy drofolate reductase homocysteine rheumatoid diseases genetic mutation
  • 相关文献

参考文献9

  • 1PETRI M,ROUBENOFF R,DALLAL G E,et al.Plasma homocysteine as a risk factor for atherothrombotic events in SLE[J].Lancet,1996,3348:1120-1124.
  • 2BOURENOFF R,DELLARIPA P,NADEAU M,et al.Abnormal homocysteine metabolism in rheumatoid arthritis[J].Arthritis Rheum,1997,40(4):718-722.
  • 3AKSU K,TURGAN N,OKSEL F,et al.Hyperhomocysteinaemia in Behcets disease[J].Rheumatology(Oxford),2001,40(6):687-690.
  • 4徐晓,肖传实,李小峰,王来远.系统性红斑狼疮与高同型半胱氨酸血症的临床研究[J].中华风湿病学杂志,2003,7(10):612-616. 被引量:8
  • 5FROSST P,BLOM H J,MILOS R,et al.A candidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate reductase[J].Nat Genet,1995,10:111-113.
  • 6BONASSI S,HAGMAR L,STROMBERG U,et al.Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens[J].Cancer Res,2000,60:1619-1625.
  • 7POGRIBNY I,YI P,JAMES S J.A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands[J].Biochem Biophys Res Commun,1999,262(3):624-628.
  • 8DENG C,KAPLAN M J,YANG J,et al.Decreased Ras-mitogen-activated protein kinase signaling may caused DNA hypomethylation in T lymphocytes from lupus patients[J].Arthritis Rheum,2001,44(2):397-407.
  • 9RICHARDSON B,SCHEINBART L,STRAHLER J,et al.Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis[J].Arthritis Rheum,1990,33:1665.

二级参考文献16

  • 1McCully KS. Vascular pathology of homocysteinemai: implications for the pathogenesis of arteriosclerosis. Am J Pathol, 1969,56 : 111-128.
  • 2Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in endstage renal disease. Circulation, 1998,97:138-141.
  • 3Omland T, Samuelsson A, Hartford M, et al. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med,2000,160:1834-1840.
  • 4Bostom AG, Gohh RY, Tsai MY, et al, Excess prevalence of fasting and postrnethionine-loading hyperhomocysteinemia in stable renal transplant recipients. Arterioscler Thromb Vasc Biol, 1997, 17:1894-1900.
  • 5Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum, 1999,42 : 338-346.
  • 6Myllykangas-Luosujarvi R, Aho K, Kautiainen H, et al. Cardiovascular mortality in women with rheumatoid arthritis. J Rheurnatol, 1995,22 : 1065-1067.
  • 7Petri M, Roubenoff R, Dallal GE, et al. Plasma homocysteine as a risk factor for atherothrombotic events in SLE. Lancet, 1996,3348:1120-1124.
  • 8Bourenoff R, Dellaripa P, Nadeau M, et al. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum, 1997, 40:718-722.
  • 9Aksu K , Turgan N , Oksel F , et al . Hyperhomocysteinernia in Behcet's disease. Rheurnatology (Oxford), 2001,40 : 687-690.
  • 10Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol, 1997,145 : 408-415.

共引文献7

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部